Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
KBR’s Mission Technology Solutions Wins Expanded Contract to Help Predict Extreme Weather, Improve Severe Storm Preparedness
-
Aalberts reports the progress of its share buyback programme 24 August – 28 August 2026
-
Zelluna ASA – Disclosure of voting rights of Extraordinary General Meeting
-
Form-8.3 APTITUDE SOFTWARE GROUP PLC - 28 08 2026 - (CGAML)
-
Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 28 08 2026 - (CGWL)
-
Peter & Sons Expands European Reach Through Partnership with NetBet
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Man Group PLC : Form 8.3 - Rotork plc
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Lithia & Driveway Invests in More than 200 Youth Nonprofits Nationwide through Lithia4Kids Community Giving Grants
-
Lithia & Driveway Invests in More than 200 Youth Nonprofits Nationwide through Lithia4Kids Community Giving Grants
-
Total Voting Rights and Capital
-
Optivate Completes Rollout of AI Documentation Suite with Launch of AI Scribe Pro
-
Weltrade Announces Synthetics Trading World Cup 2026 with $100,000 prize fund to celebrate 20th Anniversary
-
Total Voting Rights
-
GetInsured and Change and Innovation Agency Unite Under the Vimo® Name
-
2026 CIFTIS to Open Soon -- Highlights Worth Anticipating
-
The Chicago School Announces Inaugural Group of Clinical Psychology Impact Fellows
-
BICEL™ SOFT TIP I/A terralution™. Gentle by Design. Sustainable by Nature*.
-
OPPEIN Recognized by Frost & Sullivan as the Global No. 1 Customized Furnishings Brand
-
OPPEIN Recognized by Frost & Sullivan as the Global No. 1 Customized Furnishings Brand
-
Master the Moment: Global Broker FISG Appoints Football Legend Andrés Iniesta as Global Brand Experience Officer
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - Alternative Income REIT Plc
-
Hayati® Expands Its Commitment to Responsible Business Through Hayati® For Nature
-
Apeing Set to Launch Its Upcoming Crypto Presale in 8 Days, Ethereum’s 30% Weekly Rally Keeps Bullish Market Sentiment Alive
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
BTC News Today: Bitcoin Pulls Back Near $79K as Apeing’s Upcoming Crypto Presale Enters the Final 8-Day Countdown
-
At IBC, InterDigital to Showcase VVC Multilayer Coding Powering High-Quality Video Streaming
-
Cody Rhodes Enlists Millions of Gamers to Search for John Cena in Clash of Clans and WWE Crossover
-
Open Expands Motor Insurer Access with Applied Rating Hub Integration
-
ThinkMarkets Expands Weekend Trading Offering, Launches Weekend League Competition
-
Forge’s AHC 2026 Confirms Speaker Line-up Ahead of Manchester Event
-
ENA Respiratory Awarded Biointelect Venturer Funding to Support New Study in Asthma Patients of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
-
Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis
-
Transactions in connection with share buy-back program
-
Toobit's HALLU Presale Sells Out Instantly
-
Toobit's HALLU Presale Sells Out Instantly
-
Information regarding executed transactions within the framework of a share buyback programme (outside the liquidity agreement) from 24 August to 28 August 2026
-
Bank of Åland Plc: Managers' Transactions (Wiklöf)
-
Bank of Åland Plc: Managers' Transactions (Rauthovi)
-
HOFSETH BIOCARE ASA: MANAGEMENT CHANGE
-
Global Insured Catastrophe Losses Now Expected to Average $171 Billion Annually, Verisk Finds
-
Resolution Therapeutics partners with the Blood Centers of America, Inc. to support broad patient access to its experimental Regenerative Macrophage Therapy in the U.S.
-
Global Insured Catastrophe Losses Now Expected to Average $171 Billion Annually, Verisk Finds
-
Europe's Insured Losses Are Climbing as Catastrophes, Inflation and Construction Costs Combine, Verisk Finds
-
NewHydrogen Files Third Patent to Protect Its Breakthrough Technology
